3-[[[4-Methyl-5-(4-Pyridinyl)-4H-1,2,4-Triazol-3-Yl]Methyl]Amino]-N-[[2-(Trifluoromethyl)Phenyl]Methyl]-Benzamide 3-(((4-甲基-5-(吡啶-4-基)-4H-1,2,4-三唑-3-基)甲基)氨基)-N-(2-(三氟甲基)苄基)苯甲酰胺

CAS 865608-11-3 MFCD65608113

化学结构图

865608-11-3
SMILES: Cn1c(CNc2cccc(C(=O)NCc3ccccc3C(F)(F)F)c2)nnc1-c1ccncc1

别名和识别编码

Chemical Name Translation3-(((4-甲基-5-(吡啶-4-基)-4H-1,2,4-三唑-3-基)甲基)氨基)-N-(2-(三氟甲基)苄基)苯甲酰胺
PubChem Substance ID11677079
InChIInChI=1S/C24H21F3N6O/c1-33-21(31-32-22(33)16-9-11-28-12-10-16)15-29-19-7-4-6-17(13-19)23(34)30-14-18-5-2-3-8-20(18)24(25,26)27/h2-13,29H,14-15H2,1H3,(H,30,34)
Synonym 3-((4-methyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)methylamino)-N-((2-(trifluoromethyl)phenyl)methyl)benzamide CMPD101
Chemical Name3-[[[4-Methyl-5-(4-Pyridinyl)-4H-1,2,4-Triazol-3-Yl]Methyl]Amino]-N-[[2-(Trifluoromethyl)Phenyl]Methyl]-Benzamide
信息真实价格透明    资金保障    专业采购外包团队在线服务   
信息真实价格透明    资金保障    专业采购外包团队在线服务   
品牌质保精细包装    现货库存    一流品牌服务   

相关文献及参考

  • [2]. Yu Q, et al. Inhibition of prostatic smooth muscle contraction by the inhibitor of G protein-coupled receptor kinase 2/3, CMPD101.Eur J Pharmacol. 2018 Jul 15;831:9-19.
  • [1]. Okawa T, et al. Design, Synthesis, and Evaluation of the Highly Selective and Potent G-Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure. J Med Chem. 2017 Aug 24;60(16):6942-6990.
  • [1]. Okawa T, et al. Design, Synthesis, and Evaluation of the Highly Selective and Potent G-Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure. J Med Chem. 2017 Aug 24;60(16):6942-6990.
  • [2]. Yu Q, et al. Inhibition of prostatic smooth muscle contraction by the inhibitor of G protein-coupled receptor kinase 2/3, CMPD101.Eur J Pharmacol. 2018 Jul 15;831:9-19.

系列性分类

  1. Medical Research Areas
  2. Cytosketetal Signaling
  3. ROCK  (Rho相关蛋白激酶)

相关产品推荐